Eastman Chemical (NYSE: EMN) reported Q3 EPS of $2.26, $0.11 better than the analyst estimate of $2.15. Revenue for the quarter came in at $2.46 billion versus the consensus estimate of $2.38 billion.

GUIDANCE:

Eastman Chemical sees FY2024 EPS of $7.50-$7.70, versus the consensus of $7.69.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.